Albert Gandurski

Cystic echinococcosis (CE) is caused by a tapeworm of the Echinococcus granulosus s.l. species complex belonging to the Taeniidae family. CE affects more than 100 countries, including Poland, while remaining a significant public health threat to both humans and livestock. The aim of this study was to identify the genotypes responsible for cases of cystic echinococcosis in Poland by conducting molecular analysis of larvae isolated from Polish patients, and to investigate the diagnostic pathways leading to CE diagnosis. Between April 2023 and January 2025, tissue samples were collected from 10 patients following hepatectomy. Analysis of diagnostic pathways revealed that radiological findings followed by PCR or histopathological testing were sufficient to establish a reliable diagnosis of CE in 90% and 100% of cases, respectively. Serological tests showed lower sensitivity, reaching 86% for ELISA and 71% for Western blot. DNA extracted from all samples was used as the template in PCR to amplify and sequence the region of the mitochondrial NADH dehydrogenase 1 gene (nad1). PCR analysis confirmed presence of Echinococcus granulosus s.l. species in eight cases. All obtained nad1 sequences showed identity with the Echinococcus canadensis G7 (pig) strain. These results indicate that it remains the most frequent causative agent of human cystic echinococcosis in Poland.

Babesiosis is a tick-borne zoonotic disease, which is caused by various species of intracellular Babesia parasite. It is a problem not only for the livestock industry but also for global health. Significant global economic losses, in particular in cattle production, have been observed. Since the current preventive measures against babesiosis are insufficient, there is increasing pressure to develop a vaccine. In this review, we survey the achievements and recent advances in the creation of antibabesiosis vaccine. The scope of this review includes the development of a vaccine against B. microti, B. bovis, B. bigemina, B. orientalis and B. divergens. Here, we present different strategies in their progress and evaluation. Scientists worldwide are still trying to find new targets for a vaccine that would not only reduce symptoms among animals but also prevent the further spread of the disease. Molecular candidates for the production of a vaccine against various Babesia spp. are presented. Our study also describes the current prospects of vaccine evolution for successful Babesia parasites elimination.